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In Western Europe, the HIV-1 epidemic among men who have sex with men (MSM) is
dominated by subtype B. However, recently, other genetic forms have been reported to
circulate in this population, as evidenced by their grouping in clusters predominantly
comprising European individuals. Here we describe four large HIV-1 non-subtype
B clusters spreading among MSM in Spain. Samples were collected in 9 regions.
A pol fragment was amplified from plasma RNA or blood-extracted DNA. Phylogenetic
analyses were performed via maximum likelihood, including database sequences of
the same genetic forms as the identified clusters. Times and locations of the most
recent common ancestors (MRCA) of clusters were estimated with a Bayesian method.
Five large non-subtype B clusters associated with MSM were identified. The largest
one, of F1 subtype, was reported previously. The other four were of CRF02_AG
(CRF02_1; n = 115) and subtypes A1 (A1_1; n = 66), F1 (F1_3; n = 36), and C (C_7;
n = 17). Most individuals belonging to them had been diagnosed of HIV-1 infection
in the last 10 years. Each cluster comprised viruses from 3 to 8 Spanish regions and
also comprised or was related to viruses from other countries: CRF02_1 comprised
a Japanese subcluster and viruses from 8 other countries from Western Europe,
Asia, and South America; A1_1 comprised viruses from Portugal, United Kingom, and
United States, and was related to the A1 strain circulating in Greece, Albania and
Cyprus; F1_3 was related to viruses from Romania; and C_7 comprised viruses from
Portugal and was related to a virus from Mozambique. A subcluster within CRF02_1 was
associated with heterosexual transmission. Near full-length genomes of each cluster
were of uniform genetic form. Times of MRCAs of CRF02_1, A1_1, F1_3, and C_7
were estimated around 1986, 1989, 2013, and 1983, respectively. MRCA locations
for CRF02_1 and A1_1 were uncertain (however initial expansions in Spain in Madrid
and Vigo, respectively, were estimated) and were most probable in Bilbao, Spain, for
F1_3 and Portugal for C_7. These results show that the HIV-1 epidemic among MSM in
Spain is becoming increasingly diverse through the expansion of diverse non-subtype B
clusters, comprising or related to viruses circulating in other countries.
Keywords: HIV-1, molecular epidemiology, phylogeny, phylodynamics, men who have sex with men, subtypes,
circulating recombinant forms, clusters
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INTRODUCTION
HIV-1 exhibits a characteristic high genetic variability, derived
from elevated mutation and recombination rates. Through these
mechanisms, the main (M) HIV-1 group, causative of the
pandemic, has evolved into multiple genetic forms, designated
subtypes, of which nine have been identified, subsubtypes,
circulating recombinant forms (CRFs), of which 93 are currently
recognized (HIV Sequence Database, 2019; Reis et al., 2019), and
unique recombinant forms (URFs). The most globally prevalent
HIV-1 genetic form is subtype C, estimated to represent around
47% worldwide infections, followed, in this order, by subtype B,
subtype A, CRF02_AG, CRF01_AE, subtype G, and subtype D,
with each of the remaining genetic forms estimated to represent
less than 1% of global infections (Hemelaar et al., 2018).
In Western Europe, the predominant HIV-1 genetic form
is subtype B, which was initially introduced among MSM and
persons who inject drugs (PWID) (Lukashov et al., 1996; Casado
et al., 2000; Kuiken et al., 2000; Hué et al., 2005; Beloukas
et al., 2016). In early descriptions of HIV-1 genetic diversity in
Western Europe, non-subtype B genetic forms were restricted
to heterosexually infected immigrants coming from areas where
those clades predominate, mainly sub-Saharan Africans, and
European individuals epidemiologically linked to people from
such areas (Fransen et al., 1996; Op de Coul et al., 1998; Thomson
and Nájera, 2001). The first reports of HIV-1 non-subtype B
genetic forms circulating in Western Europe among individuals
without known epidemiological links to other geographic areas
described the circulation of CRF01_AE among PWID in Finland
(Liitsola et al., 2000) and of subtype G and CRF14_BG among
a minority of HIV-1-infected PWID in the region of Galicia,
Northwest Spain (Thomson et al., 2001; Delgado et al., 2002).
Subsequent studies showed that the genetic forms circulating in
Galicia derived from a subtype G variant widely circulating in
Portugal, transmitted both through sexual contact and among
PWID (Esteves et al., 2002, 2003; Palma et al., 2007; Carvalho
et al., 2015). In recent years, an increasing prevalence of non-
subtype B infections has been observed in Western Europe,
reflecting both their importation from other geographical areas
and their circulation among the local population (Abecasis
et al., 2013; Beloukas et al., 2016; Hemelaar et al., 2018;
Paraskevis et al., 2019).
In the current HIV-1 epidemic in Western Europe, the
predominant propagation mode is through sexual contact among
MSM (European Centre for Disease Prevention and Control,
2017 and WHO Regional Office for Europe 2017; Núñez et al.,
2018), a population in which a resurgence of the HIV-1 epidemic
has been observed since the 2000s, which is part of a global
phenomenon (Bezemer et al., 2008; Beyrer et al., 2012). This
has been accompanied by the emergence of phylogenetically
identifiable transmission clusters, whose expansion is mostly
driven by individuals with recent infection who are unaware of
Abbreviations: MCC, maximum clade credibility; MCMC, Markov chain Monte
Carlo; ML, maximum likelihood; MRCA, most recent common ancestor; MSM,
men who have sex with men; NFLG, near full-length genome; PP, posterior
probability; PR-RT, protease-reverse transcriptase; PWID, people who inject drugs;
tMRCA, time of most recent common ancestor.
their HIV status (Lewis et al., 2008; Cuevas et al., 2009; Bezemer
et al., 2010; Chalmet et al., 2010; Fisher et al., 2010; Zehender
et al., 2010; Ambrosioni et al., 2012; Frange et al., 2012; Thomson
et al., 2012; Audelin et al., 2013; Delgado et al., 2015; Esbjörnsson
et al., 2016; Hoenigl et al., 2016; Chaillon et al., 2017; Patiño-
Galindo et al., 2017; Parczewski et al., 2017; Verhofstede et al.,
2018; Paraskevis et al., 2019). As expected, most clusters are
of subtype B, but multiple instances of propagation of other
HIV-1 genetic forms among European MSM have also been
reported. These include subtypes A1 (Lai et al., 2016; Ragonnet-
Cronin et al., 2016), C (de Oliveira et al., 2010; Lai et al., 2014;
Ragonnet-Cronin et al., 2016), and F1 (Castro et al., 2010; Lai
et al., 2012; Thomson et al., 2012; Delgado et al., 2015; Vinken
et al., 2017; Verhofstede et al., 2018); CRF01_AE (von Wyl
et al., 2011), CRF02_AG (Giuliani et al., 2013; Brand et al.,
2014; Dauwe et al., 2015; Tamalet et al., 2015; Chaillon et al.,
2017; Verhofstede et al., 2018), CRF17_BF (Fabeni et al., 2015),
CRF19_cpx (Patiño-Galindo et al., 2015; González-Domenech
et al., 2018; Pérez-Parra et al., 2018), CRF50_A1D (Foster et al.,
2014), CRF56_cpx (Leoz et al., 2013), and CRF60_BC (Monno
et al., 2012; Simonetti et al., 2014). However, the expansion of
these clades has had a limited impact on the overall genetic
composition of the HIV-1 epidemic among MSM in Western
Europe, which is still largely dominated by subtype B. The only
exception, though geographically restricted, is a large F1 subtype
cluster of Brazilian ancestry, which represented a substantial
proportion of new HIV-1 diagnoses among MSM in Northwest
Spain (Thomson et al., 2012; Delgado et al., 2015). Here we
describe four additional large non-subtype B clusters expanding
among MSM in Spain, of CRF02_AG and of subtypes A1, F1
and C, each circulating in several Spanish regions and related to
viruses from other countries.
MATERIALS AND METHODS
Samples
Plasma or whole blood samples were collected from 1999 to
2018 from HIV-1-infected individuals attended at hospitals from
15 provinces from 9 regions of Spain (Basque Country, Galicia,
Navarre, Castilla y León, La Rioja, Madrid, Castilla-La Mancha,
Aragón, and Comunidad Valenciana). The regional sample
representativeness is variable, being the greatest in the regions
of Basque Country, where all public hospitals participated,
and Galicia, where all but one public hospitals participated.
The study was approved by the Bioethics and Animal Well-
being Committee of Instituto de Salud Carlos III, Majadahonda,
Madrid, Spain. Written informed consent was obtained from all
participants in the study.
RNA and DNA Extraction, RT-PCR
Amplification, and Sequencing
Amplification of HIV-1 fragments was done either from
plasma RNA or from DNA extracted from whole blood.
RNA was extracted from 1 ml plasma using Nuclisens
EasyMAG kit (bioMérieux, Marcy l’Etoile, France), following the
manufacturer’s instructions. DNA was extracted from 200 µl
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blood using QIAmp DNA Blood mini kit (Qiagen, Hilden,
Germany), following the manufacturer’s instructions. An HIV-
1 PR-RT fragment (approximately 1.4 kb) was amplified by
RT-PCR followed by nested PCR, in the case of RNA, or by
nested PCR, in the case of DNA, using previously reported
primers (Delgado et al., 2015). In selected samples, NFLG
amplification was done in four overlapping segments, as
described (Delgado et al., 2002; Sierra et al., 2005), using
RNA extracted either from plasma or from the primary
isolate’s culture supernatant grown from plasma using a
previously described protocol (Delgado et al., 2012). Direct
sequencing of the amplified products was done using an
automated capillary sequencer. Sequence electropherograms
were assembled and edited with Seqman (DNASTAR, Madison,
WI, United States). Newly obtained sequences are deposited
in GenBank under accessions MK177651-MK177824 (PR-RT
sequences) and MK177825-MK177829, KT276258, KY496622,
and KY989952 (NFLG sequences).
Phylogenetic Sequence Analyses
Sequences were aligned with MAFFT v.7 (Katoh and Standley,
2013). Initial trees with all sequences were constructed with
the approximate ML method implemented in FastTree
v2.1.10 (Price et al., 2010) using the general time reversible
(GTR)+CAT evolutionary model and assessment of node
support with Shimodaira-Hasegawa (SH)-like local support
values. Transmission clusters were defined as those supported
by SH-like values ≥ 0.95 comprising four or more individuals,
with a majority of them being native Spanish. To determine
whether the identified clusters were still supported when globally
sampled sequences were included and to identify viruses from
other areas belonging or phylogenetically related to them, the
analyses were repeated including all PR-RT sequences of 1 kb
or longer of the same genetic form available at the Los Alamos
HIV Sequence Database (HIV Sequence Database, 2019),
downloaded with the option “one sequence per patient.” Support
for clusters thus identified with FastTree was subsequently
assessed with phylogenetic trees constructed via ML with PhyML
v3.0 (Guindon et al., 2005), using the best-fit evolutionary model
selected by Smart Model Selection (SMS) program (Lefort et al.,
2017) and heuristic searches based on subtree pruning and
regrafting (SPR) moves, with estimation of node support by the
approximate likelihood ratio test (aLRT), SH-like procedure
(Anisimova and Gascuel, 2006; Guindon et al., 2010). To keep
computational times reasonable, in the analyses with PhyML
only several hundred sequences (around 200–400) branching
most closely to the clusters of interest in the previous FastTree
analyses, together with PR-RT sequences from NFLG from
databases, were included. Clusters were confirmed if in the
analyses including database sequences with both FastTree and
PhyML their node support values were ≥ 0.95. Trees were
visualized with Dendroscope 3 (Huson and Scornavacca, 2012)
or FigTree v1.4.21. Intersubtype recombination was analyzed
by bootscanning with Simplot v3.5 (Lole et al., 1999), with
tree construction with the neighbor-joining method, using the
1http://tree.bio.ed.ac.uk/software/figtree/
Kimura 2-parameter substitution model and windows of 400 or
600 nt moving in 20 nt steps.
Antiretroviral Drug Resistance
Determination
Antiretroviral (ARV) drug resistance was analyzed with the
Calibrated Population Resistance Tool (Gifford et al., 2009).
Temporal and Geographic Estimations of
Cluster Origins
To estimate times of the most recent common ancestors
(tMRCA) of clusters and their most probable geographical
locations, a Bayesian MCMC coalescent method as implemented
in BEAST v1.8.1 (Drummond et al., 2012) was used. Prior to
these analyses, the existence of temporal signal in the datasets
was assessed by an analysis of root-to-tip distances against
dates of sampling using TempEst (Rambaut et al., 2016). For
the BEAST analyses, we used all PR-RT sequences ≥ 1 kb
from each cluster and related sequences, as determined in the
ML phylogenetic analyses, excluding sequences without data
on year or location of sample collection. PR-RT sequences
derived from NFLG sequences of the corresponding genetic
form downloaded from the HIV Sequence Database were also
included in these analyses, using not more than 5 sequences
per country of sampling. In the case of the CRF02_1 cluster,
40 randomly selected CRF02_AG PR-RT sequences lacking
drug resistance mutations downloaded from the Los Alamos
HIV Sequences database were included, since using those
derived from NFLG resulted in relatively low r2 values in
the TempEst analysis. We chose an HKY substitution model
with gamma-distributed among-site rate heterogeneity and two
partitions in codon positions (1st+2nd; 3rd) (Shapiro et al.,
2006); uniform priors were used for absolute substitution rates
(0-0.02 sub/site/year) and relative substitution rates in codon
positions 1st+2nd and 3rd (0-10); we also used an uncorrelated
lognormal relaxed clock model and a Bayesian skyline plot
demographic model (Drummond et al., 2005). Each MCMC
chain was run for 100 million to 200 million generations,
sampling every 5,000 generations. MCMC convergence and
effective sample sizes (ESS) were checked with Tracer v.1.62,
ensuring that the ESS of each parameter was > 200. Results
were summarized with a maximum clade credibility (MCC) tree,
using TreeAnnotator v1.8.1, after removal of a 50% burn-in.
The MCC trees were visualized with FigTree v1.4.2.1 Parameter
uncertainty was summarized in the 95% highest posterior density
(HPD) intervals.
Statistical Analyses
Differences in clustering frequency between MSM and
heterosexually infected individuals and changes in proportions of
non-subtype B infections along time in newly diagnosed sexually
infected individuals were analyzed with Fisher’s exact test. Only
native Spanish individuals were included in these analyses in
order to focus on locally circulating strains, minimizing the
2http://tree.bio.ed.ac.uk/software/tracer/
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confounding effect of imported HIV-1 variants acquired in other
countries. Numbers of individuals used in these analyses were
7080 in the first and 2060 in the second.
RESULTS
Using HIV-1 PR-RT sequences from 10,506 individuals obtained
by us (whose data are summarized in Supplementary Table 1),
we identified 320 phylogenetic clusters comprising 4 or more
individuals, 247 of subtype B and 73 of other genetic forms.
Belonging to a cluster was more frequent among Spanish
MSM than among heterosexually-infected Spanish individuals
(68% vs. 31%; p = 7.7 × 10−6) (Supplementary Figure 1).
Differences were also significant when subtype B and non-
subtype B clusters were analyzed separately. An increase along
time of non-subtype B infections among newly diagnosed
Spanish individuals was also observed. Statistically significant
increases were observed in Spanish MSM from 2005–2009
to 2010–2014 (from 10.9% to 26.7%; p = 1.4 × 10−6)
and among heterosexually infected Spanish individuals from
2010–2014 to 2015–2018 (from 28.5% to 39.7%; p = 0.0097)
(Supplementary Figure 2).
Of the non-subtype B clusters, 5 large ones (here defined
as those comprising 10 or more individuals) were associated
with MSM. The largest one, of F1 subtype (currently comprising
187 individuals), was reported previously (Thomson et al., 2012;
Delgado et al., 2015). The other four were of CRF02_AG and of
subtypes A1, F1, and C, henceforth designated CRF02_1, A1_1,
F1_3, and C_7, respectively. All four clusters were well supported
when the analyses were repeated with FastTree including all PR-
RT sequences > 1 kb of the respective genetic forms available
at the Los Alamos HIV Sequence database (with numbers from
1,318 of subtype F1 to 22,762 of subtype C) and with PhyML
including several hundred (from 312 for subtype C to 513 for
CRF02_AG) database sequences branching closer to each cluster
in the FastTree analysis and derived from NFLG sequences. These
analyses also allowed to identify viruses from databases belonging
or closely related to the clusters. Epidemiological data of samples
studied by us belonging to these clusters and to subclusters within
them are shown in Table 1.
CRF02_1 Cluster
CRF02_1 comprised 115 individuals, 67 studied by us and
48 whose sequences were retrieved from databases (Figure 1).
Most samples were collected in Spain, but there were also
samples from Japan, Switzerland, United Kingdom, Ecuador,
Netherlands, Sweden, Germany, Malaysia, and Hong Kong.
Samples from Spain were from 8 regions, mainly from Basque
Country, Madrid, and Aragon.
Years of HIV-1 diagnosis were 2008–2018.
CRF02_1 comprised three subclusters, designated with
numerals 1-3. CRF02_1_1 comprised 60 individuals from 7
Spanish regions, two from United Kingdom and one from
Germany. Within it, two subsubclusters were distinguished,
associated with the Basque Country and the city of Zaragoza,
Aragón, respectively; CRF02_1_2 comprised 13 individuals
from Japan; and CRF02_1_3 comprised 11 individuals, 10 of
them from Zaragoza.
Among samples studied by us, 88% were from men.
Transmission route was sexual in the great majority, and, among
those infected via sexual contact, 51% were self-declared MSM.
Interestingly, all 10 individuals from subcluster CRF02_1_3
studied by us (5 women and 5 men, all from Zaragoza) were
infected via heterosexual contact.
Most individuals in this and in the other clusters here
described were native Spanish (Table 1).
TABLE 1 | Epidemiological data of clusters∗.
Cluster/
Subcluster
N Gender Transmission route Region Country of origin†




CRF02_1 67 58 8 1 30 12 18 1 6 31 3 3 10 15 3 1 1 53 10 4 2008–2018
1 49 47 1 1 28 12 5 1 3 26 3 1 9 6 3 1 40 7 2 2008–2018
1_1 17 17 11 4 1 1 15 2 14 2 1 2008–2018
1_2 7 7 3 1 3 1 6 6 1 2016–2018
3 10 5 5 10 9 1 8 1 1 2016–2018
A1_1 54 50 3 1 36 6 6 6 6 22 18 3 5 37 10 5 2 2006–2018
1 30 27 3 18 4 3 5 6 18 1 5 19 5 5 1 2013–2017
2 16 15 1 12 1 2 1 15 1 13 2 1 2009–2018
2_1 10 10 8 1 1 9 1 2016–2018
F1_3 36 36 17 10 3 6 30 3 3 29 6 1 2014–2018
C_7 14 14 5 6 3 4 9 1 10 1 3 2009–2017
1 8 8 5 2 1 7 6 1 1 2012–2017
2 4 4 3 1 4 3 1 2009–2015
∗Only data from samples processed by the authors are included. †Country of which the individual is native. ND, no data. HT, heterosexual. MSx, male, unspecified sexual.
BC, Basque Country. MD, Madrid. GA, Galicia. NA, Navarre. AR, Aragon. CL, Castilla y León. CM, Castilla-La Mancha. CV, Comunidad Valenciana. LR, La Rioja. LAm,
Latin American country.
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FIGURE 1 | Maximum likelihood tree of PR-RT sequences of the CRF02_1
cluster. The tree was constructed with PhyML, with assessment of node
support with the aLRT SH-like procedure. The analysis incorporates 513
CRF02_AG PR-RT sequences from databases that in preliminary analyses
with FastTree branched closer to the CRF02_1 cluster and from NFLG
sequences, and two subtype G sequences used to root the tree. For better
viewing, clades outside of the CRF02_1 cluster are collapsed. Only aLRT
SH-like node support values ≥ 0.9 are shown. Sequences obtained
by us are in bold type. Sequences from databases are labeled with the
two-letter ISO code of the country of sample collection followed by the
sample name.
A1_1 Cluster
A1_1 comprised 66 individuals, 54 studied by us and 12 with
sequences deposited in databases (7 from United Kingdom, 4
from Portugal, and 1 from United States) (Figure 2). A1_1 was
also related to viruses from the A1 subtype lineage circulating
in Greece, Albania, and Cyprus (Ciccozzi et al., 2005; Paraskevis
et al., 2007; Pineda-Peña et al., 2018). Samples from Spain were
collected in 5 regions, mainly in Galicia and Navarre.
Forty five of 47 individuals with available data were
diagnosed in 2012–2018.
Within A1_1, there were two main subclusters: A1_1_1,
comprising all individuals from Navarre, Basque Country, and La
Rioja, and 1 from Madrid; and, A1_1_2 comprising individuals
mostly from Galicia, with a majority grouping in a subsubcluster.
Most (93%) individuals in the cluster were men, with
predominance of MSM.
F1_3 Cluster
F1_3 comprised 36 individuals. There were no sequences from
databases belonging to F1_3, but viruses from Romania, most of
them transmitted sexually (Niculescu et al., 2015), were closely
related to it (Figure 3). Five viruses from Spain (4 of them
sequenced by us), 3 from United Kingdom, and 1 from Poland
also branched close to F1_3, interspersed among the Romanian
samples. Most F1_3 samples were from Basque Country.
All infections were diagnosed in 2014 or later. All individuals
in F1_3 were men. Transmission route was sexual in all for which
data were available, with a majority of MSM.
C_7 Cluster
C_7 comprised 17 individuals, including 14 studied by us and 3
from Portugal, whose sequences were retrieved from databases.
One sequence from Mozambique branched basally to C_7
(Figure 4). C_7 comprised two subclusters, C_7_1, comprising
all but one samples from Galicia, and C_7_2, comprising
all 4 samples from Basque Country. All but one had been
diagnosed in 2012–2017.
All but one Spanish samples were from Galicia or Basque
Country. All individuals in C_7 were sexually infected men, with
5 being self-declared MSM.
Bayesian Analyses and Temporal and
Geographic Estimations
To estimate the temporal and geographic origins of clusters and
subclusters, Bayesian coalescent analyses were performed with
PR-RT sequences, summarizing the posterior distribution of trees
with MCC trees. Prior to these analyses, temporal signal was
analyzed, revealing a clock-like structure in all four datasets used
for subsequent analyses (r2 = 0.4395 in CRF02_1, r2 = 0.5399 in
A1_1, r2 = 0.7175 in F1_3, and r2 = 0.3518 in C_7), indicating
that the datasets contained sufficient temporal structure for
reliable estimation of divergence times.
In the Bayesian analyses, all four clusters previously defined
via ML were supported by node PP values > 0.98.
The tMRCA of the entire CRF02_1 cluster was estimated
around 1986, but the location of the MRCA was uncertain,
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FIGURE 2 | Maximum likelihood tree of PR-RT sequences of the A1_1 cluster.
The tree was constructed with PhyML, with assessment of node support with
the aLRT SH-like procedure. The analysis incorporates 338 A1 subsubtype
PR-RT sequences from databases that in preliminary analyses with FastTree
branched closer to the A1_1 cluster and from NFLG sequences, and two
(Continued)
FIGURE 2 | Continued
CRF01_AE sequences used to root the tree. For better viewing, clades
outside of the A1_1 cluster are collapsed. Only aLRT SH-like node support
values ≥ 0.90 are shown. Sequences obtained by us are in bold type.
Sequences from databases are labeled with the two-letter ISO code of the
country of sample collection followed by the sample name. Collapsed clades
most closely related to the A1_1 cluster are labeled with the two-letter codes
of the countries of sample collection, excluding countries represented by a
single sequence.
since the most probable one was supported by a PP < 0.5.
However, the location of the MRCA of the subcluster comprising
all but the 8 most basal sequences (collected in Switzerland,
Sweden, Germany, Malaysia, and Hong Kong), with tMRCA
around 1988, had a strong support in Madrid, with a PP of
0.975 (Figure 5). Subcluster CRF02_1_1 emerged around 2002
in Madrid, CRF02_1_2 around 2006 in Japan, and CRF02_1_3
around 2006 in Zaragoza.
The estimated tMRCA of the entire A1_1 cluster was around
1989, but the location of the MRCA was uncertain, since the most
probable one was supported by a PP < 0.5. However, the location
of the MRCA of the subcluster comprising all but the 6 most basal
sequences, with tMRCA around 1994, was supported by a PP of
0.814 in the city of Vigo, Galicia. The emergence of subcluster
A1_1_1 was around 2010, with highest location PP in Pamplona,
and that of A1_1_2 was around 2004 in Vigo, Galicia (Figure 6).
It should be pointed out that 2 samples from Portugal and 6 from
United Kingdom could not be used in the Bayesian analyses, since
no collection year was available for them.
The estimated tMRCA of F1_3 was around 2013 in the city of
Bilbao, with a strongly supported ancestry in Romania (Figure 7).
Finally, the estimated tMRCA of C_7 was around 1983. Its
most probable origin was Portugal, but with a PP support for the
entire cluster of only 0.6. However, the location of the MRCA
of the subcluster comprising all but the most basal sample had
a strong support in Portugal (PP = 0.91) (Figure 8). Subcluster
C_7_1 emerged around 2008 in Vigo and C_7_2 around 2004 in
Vitoria, Basque Country.
ARV Drug Resistance Mutations
In CRF02_1, 5 sequences (4 from Spain and one from
Germany) had ARV drug resistance mutations. One was
from a drug-experienced individual in therapeutic failure with
multiple drug resistance mutations, and two, with K101E and
K103N, respectively, mutations of resistance to non-nucleoside
reverse transcriptase inhibitors (NNRTI), were from drug-
naïve individuals. The other two, with K103N and K101E
mutations, respectively, were from database sequences without
data on drug treatment. In A1_1, one database sequence from
United Kingdom had Y188C and G190A NNRTI resistance
mutations. In C_7, all but 2 sequences had L90M mutation
associated with protease inhibitor drug resistance; all 13 Spanish
sequences with this mutation were from drug-naïve individuals.
Near Full-Length Genome Sequences
To determine whether the viruses from the clusters were of
uniform genetic form all along their genomes or were interclade
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FIGURE 3 | Maximum likelihood tree of PR-RT of viruses of the F1_3 cluster.
The tree was constructed with PhyML, with assessment of node support with
the aLRT SH-like procedure. The analysis incorporates 358 PR-RT F1
subsubtype sequences from databases that in preliminary analyses with
FastTree branched closer to the F1_3 cluster and from NFLG sequences, and
two F2 subsubtype sequences used to root the tree. For better viewing,
clades outside of the F1_3 cluster, excluding those most closely related to the
F1_3 cluster, are collapsed. Only aLRT SH-like node support values ≥ 0.90
are shown. Sequences obtained by us are in bold type. Sequences from
databases are labeled with the two-letter ISO code of the country of sample
collection followed by the sample name.
FIGURE 4 | Maximum likelihood tree of PR-RT of viruses of the C_7 cluster.
The tree was constructed with PhyML, with assessment of node support with
(Continued)
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FIGURE 4 | Continued
the aLRT SH-like procedure. The analysis incorporates 312 PR-RT subtype C
sequences from databases that in preliminary analyses with FastTree
branched closer to the C_7 cluster and from NFLG sequences, and two
subtype C sequences from the Democratic Republic of Congo used to root
the tree. For better viewing, clades outside of the C_7 cluster are collapsed.
Only aLRT SH-like node support values ≥ 0.90 are shown. Sequences
obtained by us are in bold type. Sequences from databases are labeled with
the two-letter ISO code of the country of sample collection followed by
sample name.
recombinants, two NFLG sequences were obtained for each
cluster, either from plasma RNA (P2648, P3075, P4496, P4346,
and P4476) or from RNA extracted from culture supernatant
(NA0048_2, X3303_2, and X3988). An additional NFLG from
the A1_1 cluster (X2110, GenBank accession FJ670523) had been
obtained previously by us (Cuevas et al., 2010). Bootscan analyses
showed that all were of uniform genetic form along their genomes
(Figure 9). We note that NFLG sequences of two CRF02_1
viruses from United Kingdom (Figure 1) are also available at
sequence databases (Yebra et al., 2018; HIV Sequence Database,
2019) (GenBank accessions MF109381, MF109550).
DISCUSSION
In Western Europe, subtype B has been largely predominant
among MSM since the early HIV-1 epidemic, but in recent
years other genetic forms have been reported to be circulating in
this population, as evidenced by their grouping in phylogenetic
clusters comprising mostly European individuals. In this study,
based on a large dataset from Spain, we found an increase in
proportions of non-subtype B infections among MSM in recent
years (Supplementary Figure 2) and higher clustering frequency
in MSM compared to heterosexually infected individuals
(Supplementary Figure 1). Among clusters associated with
MSM, five large ones were of non-subtype B genetic forms, one
of which, of F1 subtype, was reported previously (Thomson
et al., 2012; Delgado et al., 2015). The other four were of
CRF02_AG and subtypes A1, F1, and C, for which here we
analyze epidemiological correlations, estimated emergence times
and places, NFLGs, and drug resistance mutations.
The CRF02_AG cluster (CRF02_1) comprised 115
individuals, including 67 studied by us and 48 whose sequences
were retrieved from databases, making it one of the largest
non-subtype B clusters circulating among MSM reported to date
in Western Europe (Delgado et al., 2015; Vinken et al., 2017).
CRF02_AG is the predominant HIV-1 genetic form in most
West African countries (Montavon et al., 2000; Hemelaar et al.,
2018) and is common in West-Central Africa. It also propagates
as a minor form in several Western European countries (Giuliani
et al., 2013; Brand et al., 2014; Tamalet et al., 2015; Beloukas et al.,
2016; Chaillon et al., 2017; Verhofstede et al., 2018), Tunisia
(El Moussi et al., 2017), and Brazil (Delatorre et al., 2012), and
in 2002 caused an outbreak among PWID in Uzbekistan (Carr
et al., 2005), with subsequent dissemination to Kazakhstan
(Eyzaguirre et al., 2007; Lapovok et al., 2014) and Russia
(Moskaleychik et al., 2015), giving rise to CRF63_02A1 through
recombination with the former Soviet Union subtype A variant
(Baryshev et al., 2014; Shcherbakova et al., 2014). CRF02_AG
has been reported to be one of the most common non-subtype
B genetic forms in Western Europe (together with subtypes A1
and C) (Abecasis et al., 2013; Beloukas et al., 2016; Hemelaar
et al., 2018) and in Spain (Yebra et al., 2012). The CRF02_AG
cluster here described is not completely new, since a cluster of
four individuals from the region of Valencia belonging to it was
reported by other authors, who also noted that 9 sequences from
databases, 7 from Spain and 2 from Ecuador, were related to
the Valencian cluster (Bracho et al., 2014). However, the data
here presented considerably enlarge the size and the geographic
range of the cluster. CRF02_1 comprises viruses from 8 Spanish
regions and from 9 other countries, from Western Europe, Asia
and South America, with 13 Japanese viruses grouping in a
monophyletic subcluster, indicating that it is circulating in this
country. Although CRF02_1 is mainly associated with MSM, a
subcluster comprising 11 individuals, 10 of them from the city
of Zaragoza, propagates via heterosexual contact (Table 1). The
origin of CRF02_1 is not recent, with a tMRCA estimated around
1986, with uncertain location, for the entire cluster, or 1988 in
Madrid for the subcluster excluding the 8 most basal sequences,
but its three major subclusters emerged in recent years, with
tMRCAs in the 2000s.
The A1 subtype cluster (A1_1) is the second largest cluster
here described, with 66 individuals, 54 studied by us and 12
with sequences in databases. A1 subtype circulates mainly in
Eastern, Central and Western Africa (Hemelaar et al., 2018), all
former Soviet Union (FSU) countries (Bobkova, 2013), Greece
(Paraskevis et al., 2007), Albania (Ciccozzi et al., 2005), and
Cyprus (Pineda-Peña et al., 2018), and as a minor form in
India (Pandey et al., 2016), although some authors designate
the variants circulating in Western Africa and FSU as distinct
subsubtypes (A3 and A6, respectively) (Meloni et al., 2004; Foley
et al., 2016). The lineage circulating in Greece and Albania, also
detected in Cyprus, is of monophyletic origin, with estimated
tMRCA around 1978 (Paraskevis et al., 2007). A1 subtype clusters
have been reported in United Kingdom (Gifford et al., 2007;
Hughes et al., 2009; Ragonnet-Cronin et al., 2016), Italy (Lai
et al., 2016), Switzerland (von Wyl et al., 2011), and Portugal
(Carvalho et al., 2015), but the one here reported is the largest
reported to date in Western Europe. A1_1 comprises individuals
from 5 Spanish regions and 3 other countries (United Kingdom,
Portugal, and United States), and is related to the Greek-Albanian
A1 lineage (Figure 2). Its origin is not recent, with estimated
tMRCA around 1989, with uncertain location for the entire
cluster, or around 1994 in Vigo, Galicia, excluding the 6 most
basal sequences, but its two major subclusters are of recent origin,
with tMRCAs around 2004 and 2010, respectively.
The F1 cluster (F1_3) comprises 36 individuals, all resident in
Spain, most of them in Bilbao, Basque Country. Of the clusters
here described, this is the one with the most recent origin,
with estimated tMRCA around 2013 in Bilbao. It is currently
increasing in size, with 6 individuals newly diagnosed in 2018.
Subtype F1 is circulating in Central Africa, Brazil and Romania
(Dumitrescu et al., 1994; Louwagie et al., 1994; Bandea et al., 1995;
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FIGURE 5 | Maximum clade credibility tree of PR-RT sequences of the CRF02_1 cluster. The tree also includes 40 other PR-RT CRF02_AG sequences from
databases. For better viewing, the clade comprising viruses branching outside of the CRF02_1 cluster is collapsed. Sequences obtained by us are in bold type.
Sequences from databases are labeled with the two-letter ISO code of the country of sample collection followed by the sample name. Nodes supported by PP = 1
and PP = 0.95–0.999 are marked with filled and unfilled circles, respectively. Colors of terminal and internal branches represent sampling locations and most
probable locations of the corresponding nodes, respectively, according to the legend on the left. For the nodes corresponding to CRF02_1 cluster and its major
subclusters, the location with the highest PP (if > 0.5) and the tMRCAs (with 95% HPD intervals) are indicated above or close to the subtending branches.
Apetrei et al., 1997; Op de Coul et al., 2000; Hemelaar et al., 2018),
and F1 subtype clusters have been recently identified in Spain
(Thomson et al., 2012; Delgado et al., 2015), Belgium (Vinken
et al., 2017; Verhofstede et al., 2018), Switzerland (Castro
et al., 2010), Italy (Lai et al., 2012), and Portugal (Carvalho
et al., 2015). F1_3 is most closely related to F1 viruses from
Romania (Figure 4), which are related to viruses circulating
in Angola (Guimarães et al., 2009) and initially propagated
among adults via sexual contact, with subsequent propagation
among institutionalized children through contaminated injection
equipment (Op de Coul et al., 2000; Bello et al., 2012), and more
recently among PWID (Temereanca et al., 2013; Niculescu et al.,
2015). The expansion of an F1 subtype cluster of Romanian
ancestry in Spain has its counterpart in the recent expansion
of CRF14_BG, originally described in Spain (Thomson et al.,
2001; Delgado et al., 2002) and Portugal (Esteves et al., 2003;
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FIGURE 6 | Maximum clade credibility tree of PR-RT sequences of the A1_1 cluster. The tree also includes a sequence from US that in ML trees branched close to
the A1_1 cluster (samples from United Kingdom were excluded because no information on time of sample collection was available), and A1 subsubtype PR-RT
sequences from NFLG sequences from databases. For better viewing, clades outside of the A1_1 cluster are collapsed. Sequences obtained by us are in bold type.
Sequences from databases are labeled with the two-letter ISO code of country of sample collection followed by sample name. Clades most closely related to the
A1_1 cluster are labeled with the two-letter ISO code of the sampling countries of viruses contained in it. Nodes supported by PP = 1 and PP = 0.95-0.999 are
marked with filled and unfilled circles, respectively. Colors of terminal and internal branches represent sampling locations and most probable locations of the
corresponding nodes, respectively, according to the legend on the left. For the nodes corresponding to the A1_1 cluster and its major subclusters, the location with
the highest PP (if > 0.5) and the tMRCAs (with 95% HPD intervals) are indicated above or close to the subtending branches.
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FIGURE 7 | Maximum clade credibility tree of PR-RT sequences of the F1_3 cluster. The tree also includes F1 subsubtype sequences from databases branching
close to the F1_3 cluster and F1_3 subsubtype PR-RT sequences from NFLG sequences from databases. For better viewing, clades outside of the F1 cluster are
collapsed, except those most closely related to the F1_3 cluster. Sequences obtained by us are in bold type. Sequences from databases are labeled with the
two-letter ISO code of country of sample collection followed by sample name. Nodes supported by PP = 1 and PP = 0.95–0.999 are marked with filled and unfilled
circles, respectively. Colors of terminal and internal branches represent sampling locations and most probable locations of the corresponding nodes, respectively,
according to the legend on the left. For the nodes corresponding to the F1_3 cluster and the clades within which it is contained, the location posterior probabilities
and the tMRCAs (with 95% HPD intervals) are indicated above or close to the subtending branches.
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FIGURE 8 | Maximum clade credibility tree of PR-RT sequences of the C_7 cluster. The tree also includes a subtype C sequences from Mozambique that in ML
trees branched close to the C_7 cluster and subtype C PR-RT sequences from NFLG sequences from databases. For better viewing, clades outside of the C_7
cluster are collapsed. Sequences obtained by us are in bold type. Sequences from databases are labeled with the two-letter ISO code of country of sample
collection followed by sample name. Nodes supported by PP = 1 and PP = 0.95–0.999 are marked with filled and unfilled circles, respectively. Colors of terminal and
internal branches represent sampling locations and most probable locations of the corresponding nodes, respectively, according to the legend on the left. For the
nodes corresponding to the C_7 cluster and subclusters within it, the location posterior probability and the tMRCAs (with 95% HPD intervals) are indicated above or
close to the subtending branches. tMRCA is also indicated for the node corresponding to the clade including the sample from Mozambique (most probable location
is omitted, since its PP is below 0.5).
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FIGURE 9 | Bootscan analyses of NFLG sequences of viruses from the identified clusters. Virus names, with cluster in parentheses, are above each plot. A window
of 400 nt was used for viruses of the A1_1, F1_3, and C_7 clusters, and of 600 nt for viruses of the CRF02_1 cluster, sliding in 20 nt increments. The horizontal axis
represents the nucleotide position in the HXB2 proviral genome of the window’s midpoint. The vertical axis represents the bootstrap value supporting clustering with
reference sequences, listed on the right of each plot.
Abecasis et al., 2011; Bartolo et al., 2011), among PWID in
Romania (Niculescu et al., 2015). The exchange of HIV-1 genetic
forms between Romania and Spain reflects the presence of a large
Romanian immigrant population in Spain (Instituto Nacional de
Estadística, 2018), frequently traveling between both countries.
The subtype C cluster (C_7) comprises 17 viruses, 14 from
three Spanish regions, predominantly from Galicia, and three
from Portugal. It comprises a Galician and a Basque subclusters
(Figure 4). This is not the first report of this cluster, as it was
described by us when it comprised only 7 individuals, within
the context of the description of HIV-1 clusters bearing ARV
drug resistance mutations, noting that viruses belonging to it
carry the L90M mutation of resistance to protease inhibitors
(Vega et al., 2015). This mutation was found in 15 of 17 C_7
viruses. Subtype C is the most prevalent clade in the HIV-1
pandemic, circulating mainly in Southern and Eastern Africa,
Southern Brazil, and South Asia (Hemelaar et al., 2018). In
Western Europe, subtype C clusters have been reported in the
United Kingdom (Hughes et al., 2009; de Oliveira et al., 2010;
Ragonnet-Cronin et al., 2016), Italy (Lai et al., 2014), and
Portugal (Carvalho et al., 2015).
The origin of C_7 is not recent, with a tMRCA around 1983,
with a most probable origin in Portugal, but the tMRCAs of its
subclusters are relatively recent, in 2008 and 2004, respectively.
C_7 is related to a virus from Mozambique, a former Portuguese
colony where subtype C is the predominant HIV-1 genetic form
(Bellocchi et al., 2005).
It should be noted that 3 individuals in each of clusters F1_3
and C_7, composed entirely of men, declared being heterosexual,
and that in clusters CRF02_1 (excluding the heterosexual-
associated CRF02_1_3 subcluster) and A1_1, among sexually
infected individuals the number of self-declared heterosexual
men exceeds the number of women (8 vs. 3 in CRF02_1 and 6 vs.
3 in A1_1). This suggests that at least some of the self-declared
heterosexual men within the clusters could in fact be MSM, who,
due to social stigma and discrimination, do not declare their real
sexual behaviors, as suggested by other authors who found similar
discrepancies between self-reported heterosexual behavior and
phylogenetic clustering with sequences from MSM (Hué et al.,
2014; Hoenigl et al., 2016; Ragonnet-Cronin et al., 2018).
The descriptions of the four clusters here analyzed is in line
with those of other non-subtype B clusters reported to have
expanded among MSM in Western Europe. However there are
some salient features of the clusters here described that should
be highlighted: first, the relatively large size of CRF02_1_1
and A1_1, greater than most non-subtype B clusters reported
among MSM in Western Europe; second, their wide geographic
distribution among different countries, which contrasts with the
predominantly within-country clustering found by other authors
in Europe (Frentz et al., 2013; Paraskevis et al., 2019); and, third,
the rapid expansion of F1_3, with 36 diagnoses in only 4 years.
The expansion of large clusters among MSM in recent
years, as here reported, reflects the existence of high risk
sexual behaviors, which should prompt public health authorities
to implement public health measures aimed at preventing
HIV-1 transmission in this population, including behavioral
interventions to reduce risky practices, preexposure prophylaxis
(Grant et al., 2010; Volk et al., 2015; McCormack et al., 2016),
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and early diagnosis and treatment of HIV-1 infections (European
Centre for Disease Prevention and Control, 2015; United Nations
Population Fund, the Global Forum on MSM and HIV, United
Nations Development Programme, World Health Organization,
United States Agency for International Development, and World
Bank, 2015). Prevention of HIV-1 transmission among MSM
could also result in a reduction of heterosexually-transmitted
infections, which can have their source in MSM networks,
as seen in subcluster CRF02_1_3, associated with heterosexual
transmission, and as reported by other authors (Oster et al., 2015;
Esbjörnsson et al., 2016).
Continued HIV-1 molecular surveillance will be necessary
to gain insight in real time on the dynamics of expansion of
transmission networks, which will allow to focus prophylactic
efforts in populations with the highest risk of HIV-1 acquisition
and ongoing transmission (Little et al., 2014; Wang et al.,
2015; Poon et al., 2016; Ratmann et al., 2016; Brenner et al.,
2017; Chaillon et al., 2017; German et al., 2017; Oster et al.,
2018; Wertheim et al., 2018) and to monitor the efficacy of
public health interventions aimed at controlling the epidemic
(Wertheim et al., 2011; Magiorkinis et al., 2018). HIV-1 molecular
surveillance can also provide important information for the
design of vaccine immunogens adapted to the major HIV-1
variants actively propagating in different areas, considering the
correlation of HIV-1 clades to susceptibility to protective immune
responses (Cao et al., 2000; Thomson et al., 2002; Binley et al.,
2004; Geldmacher et al., 2007; Seaman et al., 2010; Hraber et al.,
2014), and with potential to induce broadly neutralizing antibody
responses (Kouyos et al., 2018), and will allow to obtain reagents
derived from these variants for use in vaccine-related research
(Cuevas et al., 2010; Revilla et al., 2011; Hora et al., 2016). These
reagents will also be useful for studies on the biological basis
of increased pathogenicity (Baeten et al., 2007; Kiwanuka et al.,
2010; Li et al., 2014; Pérez-Álvarez et al., 2014; Kouri et al.,
2015; Venner et al., 2016) and transmissibility (Kiwanuka et al.,
2009) and diminished response to ARV drugs (Pernas et al., 2014;
Cid-Silva et al., 2018) exhibited by some HIV-1 variants.
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